PABYX
Price
$17.63
Change
+$0.06 (+0.34%)
Updated
Oct 8 closing price
Net Assets
2.34B
RLBAX
Price
$38.73
Change
+$0.17 (+0.44%)
Updated
Oct 8 closing price
Net Assets
266.1B
Interact to see
Advertisement

PABYX vs RLBAX

Header iconPABYX vs RLBAX Comparison
Open Charts PABYX vs RLBAXBanner chart's image
Putnam Dynamic Asset Allocation Bal Y
Price$17.63
Change+$0.06 (+0.34%)
VolumeN/A
Net Assets2.34B
American Funds American Balanced R1
Price$38.73
Change+$0.17 (+0.44%)
VolumeN/A
Net Assets266.1B
PABYX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
PABYX vs. RLBAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABYX is a Hold and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. PABYX (2.34B). PABYX pays higher dividends than RLBAX: PABYX (2.58) vs RLBAX (1.10). PABYX was incepted earlier than RLBAX: PABYX (31 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than PABYX (0.68). PABYX is a more actively managed with annual turnover of: 222.00 vs. RLBAX (44.00). PABYX has a lower initial minimum investment than RLBAX: PABYX (0) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 9.08 vs. PABYX (4.08). RLBAX return over 5 years is better than : 38.13 vs. PABYX (23.15).
PABYXRLBAXPABYX / RLBAX
Total Expense Ratio0.681.3152%
Annual Report Gross Expense Ratio0.681.3152%
Fund Existence31 years23 years-
Gain YTD12.98514.27191%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B266B1%
Annual Yield % from dividends2.581.10234%
Returns for 1 year4.089.0845%
Returns for 3 years39.8448.6482%
Returns for 5 years23.1538.1361%
Returns for 10 years46.0069.4666%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVP0.990.01
+1.31%
Inspire Veterinary Partners Inc
GRRR20.220.23
+1.15%
Gorilla Technology Group
ROIV16.03-0.09
-0.56%
Roivant Sciences Ltd
PRLD1.42-0.02
-1.39%
Prelude Therapeutics
WLY36.77-1.56
-4.07%
John Wiley & Sons